Don’t miss out on our latest stories. Add PCMag as a preferred source on Google.
Elon Musk’s brain implant start-up, Neuralink, plans to launch a US clinical trial next month of a device that it says can translate thoughts into text.
The company’s president and co-founder, Seo Dong-jin, claims that the US Food and Drug Administration has granted Neuralink an “investigational device exemption” ahead of the trial, allowing it to test unapproved products in humans, according to…








